News | February 11, 2022
Marksans Pharma Q3FY22 PAT at Rs. 48.27 crore
Marksans Pharma has reported consolidated financial results for the period ended December 31, 2021
Marksans Pharma has reported consolidated financial results for the period ended December 31, 2021
The Ayurveda storefront will enhance visibility of unique Ayurveda products from Indian small businesses and D2C brands
The awards will be conferred to the winners at the annual summit of OPPI, scheduled on March 23-24
Adds five years of market exclusivity on approval
On track to complete the BLA submission in the first half of 2022
The vagus nerve is the longest nerve in the body that travels down from the brain to innervate and control breathing, stress levels and inflammation
Urban, semi-urban and remote corners of the country will be catered using drone delivery technology
FortePhest is developing a new technology to combat herbicide-resistant weeds and invasive plants
MedleyMed is present across the pharma and healthcare value chain. It offers digital solutions to all stake holders and is in the process of expanding its operations in India and USA. In an interview with Thomas C Thottathil, M Satyendra (Satish), Managing Director, Athena Global Technologies & MedleyMed discussed his plans and opportunities in India
Glenmark received manufacturing and marketing approval from DCGI for Nitric Oxide Nasal Spray (NONS) as part of accelerated approval process
Subscribe To Our Newsletter & Stay Updated
